Skip to main content
. 2018 May 29;20:96. doi: 10.1186/s13075-018-1598-8

Table 1.

Baseline characteristics of the 1003 AS patients and 1747 RA patients who were working at baseline

Parameter AS n RA n
Age (years), mean (SD) 40.7 (10.6) 1003 47.3 (9.9) 1747
Female, % 36.7 1003 72.4 1747
Disease duration (years), mean (SD) 7.3 (7.8) 979 7.9 (7.6) 1654
Disease activity 0–10 Likert, mean (SD) 6.3 (1.7) 1000
0–100 mm VAS, mean (SD) 59.1 (18.0) 1724
CRP (mg/dL), median (min, max) 1.0 (0.0, 42.7) 906 0.9 (0.0, 20.0) 1534
Fatigue 0–10 cm VAS, mean (SD) 5.6 (2.4) 997
0–100 mm VAS, mean (SD) 57.4 (24.9) 1735
Pain 0–10 Likert, mean (SD) 6.3 (2.2) 990
0–100 mm VAS, mean (SD) 61.6 (21.4) 1736
Anxiety/depression
(EQ-5D)
No problems, % 53.6 998 52.1 1738
Some problems, % 42.7 44.4
Extreme problems, % 3.7 3.6
WPAI:SHP
% work time missed due to AS/RAa No timed missed 61.9 776 61.3 1293
Some time missed 38.1 38.7
% impairment while working due to AS/RAb, mean (SD) 48.3 (26.9) 889 49.5 (27.1) 1530
% overall work impairment due to AS/RAc, mean (SD) 52.9 (29.8) 716 54.1 (29.0) 1171
% activity impairment due to AS/RAd, mean (SD) 53.4 (24.6) 990 54.0 (24.9) 1718

aAbsenteeism

bPresenteeism

cWork productivity loss

dActivity impairment

AS, ankylosing spondylitis; CRP, C-reactive protein; EQ-5D, European Quality of Life 5 Dimensions; RA, rheumatoid arthritis; SD, standard deviation; VAS, visual analogue scale; WPAI:SHP, Work Productivity and Activity Impairment—Special Health Problems